X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
32
PharmaCompass offers a list of Azilsartan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Azilsartan manufacturer or Azilsartan supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Azilsartan manufacturer or Azilsartan supplier.
PharmaCompass also assists you with knowing the Azilsartan API Price utilized in the formulation of products. Azilsartan API Price is not always fixed or binding as the Azilsartan Price is obtained through a variety of data sources. The Azilsartan Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A UNII-WEC6I2K1FC manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of UNII-WEC6I2K1FC, including repackagers and relabelers. The FDA regulates UNII-WEC6I2K1FC manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. UNII-WEC6I2K1FC API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of UNII-WEC6I2K1FC manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A UNII-WEC6I2K1FC supplier is an individual or a company that provides UNII-WEC6I2K1FC active pharmaceutical ingredient (API) or UNII-WEC6I2K1FC finished formulations upon request. The UNII-WEC6I2K1FC suppliers may include UNII-WEC6I2K1FC API manufacturers, exporters, distributors and traders.
click here to find a list of UNII-WEC6I2K1FC suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A UNII-WEC6I2K1FC DMF (Drug Master File) is a document detailing the whole manufacturing process of UNII-WEC6I2K1FC active pharmaceutical ingredient (API) in detail. Different forms of UNII-WEC6I2K1FC DMFs exist exist since differing nations have different regulations, such as UNII-WEC6I2K1FC USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A UNII-WEC6I2K1FC DMF submitted to regulatory agencies in the US is known as a USDMF. UNII-WEC6I2K1FC USDMF includes data on UNII-WEC6I2K1FC's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The UNII-WEC6I2K1FC USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of UNII-WEC6I2K1FC suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The UNII-WEC6I2K1FC Drug Master File in Japan (UNII-WEC6I2K1FC JDMF) empowers UNII-WEC6I2K1FC API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the UNII-WEC6I2K1FC JDMF during the approval evaluation for pharmaceutical products. At the time of UNII-WEC6I2K1FC JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of UNII-WEC6I2K1FC suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a UNII-WEC6I2K1FC Drug Master File in Korea (UNII-WEC6I2K1FC KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of UNII-WEC6I2K1FC. The MFDS reviews the UNII-WEC6I2K1FC KDMF as part of the drug registration process and uses the information provided in the UNII-WEC6I2K1FC KDMF to evaluate the safety and efficacy of the drug.
After submitting a UNII-WEC6I2K1FC KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their UNII-WEC6I2K1FC API can apply through the Korea Drug Master File (KDMF).
click here to find a list of UNII-WEC6I2K1FC suppliers with KDMF on PharmaCompass.
A UNII-WEC6I2K1FC written confirmation (UNII-WEC6I2K1FC WC) is an official document issued by a regulatory agency to a UNII-WEC6I2K1FC manufacturer, verifying that the manufacturing facility of a UNII-WEC6I2K1FC active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting UNII-WEC6I2K1FC APIs or UNII-WEC6I2K1FC finished pharmaceutical products to another nation, regulatory agencies frequently require a UNII-WEC6I2K1FC WC (written confirmation) as part of the regulatory process.
click here to find a list of UNII-WEC6I2K1FC suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing UNII-WEC6I2K1FC as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for UNII-WEC6I2K1FC API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture UNII-WEC6I2K1FC as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain UNII-WEC6I2K1FC and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a UNII-WEC6I2K1FC NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of UNII-WEC6I2K1FC suppliers with NDC on PharmaCompass.
UNII-WEC6I2K1FC Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of UNII-WEC6I2K1FC GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right UNII-WEC6I2K1FC GMP manufacturer or UNII-WEC6I2K1FC GMP API supplier for your needs.
A UNII-WEC6I2K1FC CoA (Certificate of Analysis) is a formal document that attests to UNII-WEC6I2K1FC's compliance with UNII-WEC6I2K1FC specifications and serves as a tool for batch-level quality control.
UNII-WEC6I2K1FC CoA mostly includes findings from lab analyses of a specific batch. For each UNII-WEC6I2K1FC CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
UNII-WEC6I2K1FC may be tested according to a variety of international standards, such as European Pharmacopoeia (UNII-WEC6I2K1FC EP), UNII-WEC6I2K1FC JP (Japanese Pharmacopeia) and the US Pharmacopoeia (UNII-WEC6I2K1FC USP).
Market Place
